Magazine
MindMed’s CEO Jamon “JR” Rahn Wants Nothing To Do With Those Psychedelic Decrim People
“I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes.”
Russell Hausfeld
Magazine
Field Trip Announces “World’s First” Virtual Psychedelic Therapy, But Forgets To Mention They Aren’t the First and No Psychedelics Are Involved
Field Trip Ventures leads the charge to use “psychedelic” as a marketing buzzword for any kind of niche therapy.
Magazine
Psychedelic Video Museum Celebrates Virtual Launch
Contributors to the Daily Psychedelic Video platform gather on Zoom to bless the opening of the Psychedelic Video Museum: a collection of ten years’ worth of their shared visions.
Magazine
Indie Film ‘Debbie and Doug Drop Acid in the Desert’ is a Visual and Emotional Trip
‘Debbie and Doug Drop Acid in the Desert’ director, Scott Brown, talks mind-altering drugs, creating psychedelic visual effects, and dealing with depression.
Magazine
How psychedelic clinical trials are being affected by coronavirus
Almost all clinical psychedelic drug research is being affected in some way or another by COVID-19. But, response measures vary from one organization to the next.
Magazine
Ayahuasca Healings’ Trinity de Guzman calls coronavirus “a necessary purge”
“The Corona Virus is a necessary purge of what is no longer in resonance,” Trinity de Guzman wrote in a recent email to his followers.
Magazine
Native American Churches Request that Peyote Not Be Included in Decriminalization Initiatives
A long-fought battle for access to peyote, and a dwindling population in the United States has led Native American Church members and peyote conservationists to request that peyote be left out of decriminalization efforts.
Magazine
Calm Down. What’s the Worst Thing That the Wellness Industry Could Do to Psychedelics?
As technology and psychedelics turn to mental health, we’ll likely see a future where we are treated based on our digital biomarkers, and sold mental health services based on the personal data we surrender.
Magazine
Talking Psychedelic Capitalism in a WeWork Ballroom
Psychedelic capitalists justify their decision to go for-profit in the ballroom of America’s most recent for-profit flop.
Magazine
Christian Angermayer’s ATAI Life Sciences is positioned to take the psychedelic throne from MAPS
After decades of psychedelic nonprofits paving regulatory pathways and priming wealthy investors, for-profits are moving in to reap the rewards.
Magazine
“Making psychedelics boring again”— Unless you’re a privileged psychedelic executive, of course
The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.
Magazine
Psychedelic Trade Secrets and Get-Rich-Quick Schemes —a Benefit to Investors, a Harm to Progress
“Play the field right and there’s money to be made even off some of the shit companies purely based on the wave.”